The contract for the design and development of the CytoBase system was awarded to Artificial Intelligence in Medicine Inc. (AIM), a Toronto based software engineering firm specializing in information systems for the healthcare industry. The conceptual design and specifications for the system were developed by AIM with the participation of experts from the laboratory industry, the Ontario Cancer Treatment and Research Foundation, the legal industry, and the Ministry of Health. Preliminary design and proof of concept of the system dates to February of 1994. Full scale development started in June of 1995, with production operations starting in 1996.
Inspirata Inc., headquartered in Tampa FL, is a global cancer informatics company providing solutions that bring together disparate data throughout the entire cancer care journey to drive informed decisions that improve survivorship.
Inspirata Inc. acquired AIM on January 1, 2018 and the company was renamed Inspirata Canada.
Inspirata Canada is Inscyte's agent in respect of the on-going operations, maintenance and upgrades of the CytoBase platform. Inspirata Canada implements and administers Inscyte's Privacy & Security Policies and Procedures in the day-to-day operations of CytoBase.
For more information about Inspirata please visit Inspirata.com